Literature DB >> 13480952

Effect of glucagon on food intake and body weight in man.

J L SCHULMAN, J L CARLETON, G WHITNEY, J C WHITEHORN.   

Abstract

Entities:  

Keywords:  BODY WEIGHT/effect of drugs on; FOOD; GLUCAGON/effects; HUNGER/effect of drugs on

Mesh：

Substances：

Year:  1957        PMID： 13480952     DOI： 10.1152/jappl.1957.11.3.419

Source DB:  PubMed          Journal:  J Appl Physiol        ISSN： 0021-8987            Impact factor:   3.531


× No keyword cloud information.
  35 in total

1.  The physiology of symptoms. II. Regulation of food intake.

Authors:  M I GROSSMAN
Journal:  Am J Dig Dis       Date:  1958-09

Review 2.  Minireview: Glucagon in stress and energy homeostasis.

Authors:  B J Jones; T Tan; S R Bloom
Journal:  Endocrinology       Date:  2012-01-31       Impact factor: 4.736

Review 3.  Bowels control brain: gut hormones and obesity.

Authors:  Benjamin C T Field; Owais B Chaudhri; Stephen R Bloom
Journal:  Nat Rev Endocrinol       Date:  2010-06-29       Impact factor: 43.330

Review 4.  Role of Glucagon in Automated Insulin Delivery.

Authors:  Leah M Wilson; Peter G Jacobs; Jessica R Castle
Journal:  Endocrinol Metab Clin North Am       Date:  2019-12-10       Impact factor: 4.741

5.  A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood.

Authors:  Pauline Teuffel; Miriam Goebel-Stengel; Tobias Hofmann; Philip Prinz; Sophie Scharner; Jan L Körner; Carsten Grötzinger; Matthias Rose; Burghard F Klapp; Andreas Stengel
Journal:  J Vis Exp       Date:  2016-04-28       Impact factor: 1.355

Review 6.  The alpha-cell as target for type 2 diabetes therapy.

Authors:  Mikkel Christensen; Jonatan I Bagger; Tina Vilsbøll; Filip K Knop
Journal:  Rev Diabet Stud       Date:  2011-11-10

Review 7.  Satietin; a 50,000 dalton glycoprotein in human serum with potent, long-lasting and selective anorectic activity.

Authors:  J Knoll
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

8.  Satietin, a blood-borne anorectic glycoprotein, as the putative rate-limiting satiety signal in the negative feed-back of food intake.

Authors:  J Knoll
Journal:  Z Ernahrungswiss       Date:  1984-06

Review 9.  Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon.

Authors:  Gitanjali Srivastava; Caroline Apovian
Journal:  Curr Obes Rep       Date:  2018-06

10.  Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice.

Authors:  Alessandro Pocai; Paul E Carrington; Jennifer R Adams; Michael Wright; George Eiermann; Lan Zhu; Xiaobing Du; Aleksandr Petrov; Michael E Lassman; Guoqiang Jiang; Franklin Liu; Corey Miller; Laurie M Tota; Gaochao Zhou; Xiaoping Zhang; Michael M Sountis; Alessia Santoprete; Elena Capito'; Gary G Chicchi; Nancy Thornberry; Elisabetta Bianchi; Antonello Pessi; Donald J Marsh; Ranabir SinhaRoy
Journal:  Diabetes       Date:  2009-07-14       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.